Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Financing
Optimer Announces $35.9 Million Private Placement
November 9th, 2007
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced that it has entered into a securities purchase agreement with certain institutional investors to raise $35.9 million from the private placement of 4.6 million newly issued shares of its common stock, at a price of $7.80 per share. Subject to the satisfaction of customary closing conditions, the financing is expected to close on or about October 29, 2007. Piper Jaffray & Co. acted as exclusive placement agent for this offering. The shares of Optimer's common stock to be sold in the private placement have not been registered under the Securities Act of 1933, as amended, or state securities laws and...
Source: Biotech Law Weekly (2007-11-09)
|
